Effective strategies for the prevention and mitigation of phosphatidylinositol-3-kinase inhibitor-associated hyperglycemia: optimizing patient care

HN Moore, MD Goncalves, AM Johnston, EL Mayer… - Clinical breast …, 2024 - Elsevier
Hyperglycemia is a common adverse event (AE) associated with phosphatidylinositol-3-
kinase inhibitors (PI3Kis) and considered an on-target effect. Presence of hyperglycemia is …

[HTML][HTML] Paraneoplastic hypoglycemia: An overview for optimal clinical guidance

NN Karamanolis, D Kounatidis, NG Vallianou… - Metabolism Open, 2024 - Elsevier
Paraneoplastic hypoglycemia, also known as non-islet cell tumor hypoglycemia (NICTH), is
a rare but critical condition occurring in patients with different types of malignancy. This …

Adjuvant Alpelisib Therapy for Congenital Hyperinsulinism

H Dauleh, R Amin, M Pasha… - New England Journal of …, 2024 - Mass Medical Soc
Adjuvant Alpelisib Therapy for Congenital Hyperinsulinism | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …

[PDF][PDF] Recurrent Hypoglycemia in a Non-diabetic Female: A Case Study on Doege-Potter Syndrome

SR Mohammed, N Mack, V Ramoutar, J Rampersad… - Cureus, 2024 - cureus.com
Solitary fibrous tumors (SFT) are mesenchymal cell tumors that may arise from any site
throughout the body. A small percentage of patients with SFT develop non-islet cell tumor …